(+)-Galactosamine HCl—the cornerstone molecule for building targeted therapies CAS: 1772-03-8

D(+)-galactosamine hydrochloride, as a key tool molecule in the fields of glycobiology and liver research, is far more than a simple amino sugar. It is the "precision key" to explore the physiological and pathological mechanisms of the liver, and it is also the "core component" to develop innovative liver-targeted therapies. From basic scientific research to drug development, it has shown irreplaceable value in revealing the principles of disease and building new delivery platforms.

Chemical Information

Chemical name: 2-amino-2-deoxy-D-galactose hydrochloride

Common name: D(+)-galactosamine hydrochloride

Chemical formula: C6H14ClNO5

Molecular weight: 215.63 g/mol

CAS number: 1772-03-8

Category: Monosaccharides

Structural characteristics and basis of biological activity

D-galactosamine is an amino derivative of galactose. Its unique structure gives it specific biological activity:

Key amino modification: replacing the hydroxyl group (-OH) with an amino group (-NH2) at the C2 position of galactose. This modification enables it to selectively interfere with the uridylic acid metabolism pathway in liver cells.

Specific liver cell targeting: This structure can be efficiently taken up and metabolized by liver cells. By competitively inhibiting the synthesis of key metabolites such as UTP, it blocks the synthesis of RNA and glycoprotein in liver cells, thereby achieving specific regulation of liver function.

Building module function: Its amino group provides an active reaction site for subsequent chemical modifications (such as conjugation with drug molecules), and is an important precursor for constructing liver-targeted drug delivery systems.

Core application and scientific value

1. The “gold standard” modeling tool for liver disease research

D-galactosamine is the most classic and widely used chemical inducer for establishing experimental liver injury animal models (especially acute liver failure models). Its mechanism of action highly simulates the immune-mediated injury process involved in human liver diseases such as viral hepatitis, and can reliably induce liver injury accompanied by necrosis, inflammation and apoptosis, providing an indispensable standardized platform for studying the pathological mechanisms of liver diseases and evaluating the efficacy of hepatoprotective drugs.

2. Key precursors for glycobiology and glycoprotein synthesis research

As a natural amino sugar, D-galactosamine is an important metabolic substrate for the biosynthesis of glycoproteins, proteoglycans (such as chondroitin sulfate), and glycolipids. In research, it can be used for:

Metabolic labeling and tracking: Study of glycosylation processes and biosynthetic pathways of glycoconjugates.

Modulating sugar chain structure: By interfering with metabolism, explore the impact of specific sugar chain structures on protein function, cell signal recognition, and cell adhesion.

3. Core ligands for liver-targeted drug delivery systems

With its hepatocyte-specific uptake properties, D-galactosamine has become a star molecule in designing liver-targeted drug delivery systems:

Active targeting carrier: Through covalent linkage, galactosamine is used as a target modified on nanoliposomes, polymeric nanoparticles or the drug molecule itself, so that it can be specifically recognized and endocytosed by the asialoglycoprotein receptor (ASGPR) highly expressed on the surface of hepatocytes.

Improve the therapeutic index: This strategy can significantly increase the accumulation of drugs in the liver, while reducing the toxic and side effects on other organs, providing an efficient delivery solution for the treatment of liver cancer, liver fibrosis, hepatitis and liver genetic metabolic diseases.

4. Research on immune regulation and inflammation

D-galactosamine significantly enhances liver sensitivity to endogenous inflammatory mediators such as tumor necrosis factor-α (TNF-α). This property makes it a powerful tool model for studying liver immunopathology, cytokine storm, and screening anti-inflammatory and anti-apoptotic drugs.

Conclusion

D(+)-galactosamine hydrochloride, from a molecule that revealed the mechanism of liver toxicity, has evolved into a bridge between basic research and translational medicine. Its multifunctional role in accurately constructing disease models, decoding glycobiological codes, and empowering the next generation of liver-targeted therapies demonstrates its enduring value as a core scientific research reagent and the cornerstone of drug development.

The above information is provided by the editor of KASONS and is for scientific research only.